Newsletter

Generalized Myasthenia Gravis
A chronic autoimmune neuromuscular disease with almost 55% of the cases diagnosed in the US in the 7MM, gMG has managed to garner the attention of several pharma companies
Generalized Myasthenia Gravis Newsletter

More Whitepapers / Newsletters

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required for the break-down of glucocerebroside thus causing a build-up in ar...

Herpes Zoster Oticus
Herpes Zoster Oticus

Herpes zoster oticus (HZ oticus) is a viral infection of the inner, middle, and external ear. A result of reactivation of varicella-zoster virus infection, it manifests as severe otalgia and associate...

Rethinking medtech in Covid times
Rethinking medtech in Covid ti...

COVID-19 transforms healthcare facets at an unprecedented pace. Based on emerging technology, we can be reasonably sure that the bulk of the change will be powered by the digital transformation made p...

Adult Onset Still's Disease
Adult Onset Still's Disease

Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthritis that affects most people before the age of 45. The symptoms of the disease usually begin with a...

Gene Therapy Outlook
Gene Therapy Outlook 2020

Gene Therapy has shown tremendous growth in the past few years. The use of AAV (adeno-associated virus) and CAR-T cell immunotherapy has made success in the gene therapy segment in 2000s and in the pr...